Diabetes & CV Disease
Sort by:
AHA 2023 Insights
AHA 2023 Insights: Reflections on SELECT Trial
FEATURING
Donna Ryan
- 2,079 views
- November 21, 2023
- 11
Primary Care Education Consortium
Road Map & Speed Bumps in the Management of T2DM
FEATURING
Louis Kuritzky
- 247 views
- November 21, 2023
- 1
Primary Care Education Consortium
Cardiovascular and Kidney Outcomes With Glucose-Lowering Agents
FEATURING
James Gavin Iii
- 989 views
- November 21, 2023
- 8
Jefferson Health
11th Annual Diabetes Symposium: Cases for Discussion
FEATURING
Serge Jabbour,
Jeffrey Miller,
Intekhab Ahmed,
Barbara Simon,
Monika Shirodkar,
Jessica Watari,
Kevin Furlong,
Erin Galuchie England,
Cheryl Marco,
Lubna Zuberi
- 15 views
- November 23, 2023
Jefferson Health
Inpatient Diabetes Management: An Update
FEATURING
Eric Shiffrin
- 338 views
- November 23, 2023
- 3
Jefferson Health
Managing Type 2 Diabetes: Preconception to Delivery
FEATURING
Lubna Zuberi
- 153 views
- November 23, 2023
- 2
Jefferson Health
Diabetes Technology: A Practical Guide
FEATURING
Erin Galuchie England,
Cheryl Marco
- 436 views
- November 23, 2023
- 2
Jefferson Health
Diabesity: New Trends in Management
FEATURING
Kevin Furlong
- 846 views
- November 23, 2023
- 11
Jefferson Health
Latent Autoimmune Diabetes in Adults & Posttransplantation DM
FEATURING
Jessica Watari
- 341 views
- November 23, 2023
- 3
Jefferson Health
Flavors of Diabetes - Maturity Onset of the Young (MODY)
FEATURING
Monika Shirodkar
- 221 views
- November 23, 2023
- 1
Jefferson Health
Insulin Therapy: When, How and Much More
FEATURING
Barbara Simon
- 500 views
- November 23, 2023
- 4
AHA 2023 Insights
AHA 2023 Insights: SGLT2 Inhibitors - Clinical Questions for HFpEF That Are Yet to Be Answered Back to the Lab
FEATURING
Joseph Hill
- 640 views
- November 23, 2023
- 8
AHA 2023 Insights
AHA 2023 Insights: Estimated Lifetime Benefits of SGLT2i, GLP-1 RA and ns-MRA in People with Type 2 Diabetes and Albuminuria
FEATURING
Brendon Neuen
- 188 views
- November 23, 2023
- 2
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
Reducing Cardiometabolic Risk with SGLT2i and GLP1-RA – How to Choose and in Who
FEATURING
Qin Yang
- 954 views
- November 24, 2023
- 5
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
Pillars of Therapy for Prevention of CVD in CKD Patients – the Cardiorenal Syndrome
FEATURING
Christian Mende
- 1,083 views
- November 27, 2023
- 12
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
LDL-C: Earlier and Lower Is Better and Safer?
FEATURING
Paul Rosenblit
- 3,882 views
- November 27, 2023
- 19
ISPAD - International Society for Pediatric and Adolescent Diabetes
Glycemic Targets: Q&A Discussion
- 6 views
- November 27, 2023
ISPAD - International Society for Pediatric and Adolescent Diabetes
A Psychosocial Perspective on Glycemic Targets
FEATURING
Maartje Dewit
- 2 views
- November 27, 2023
ISPAD - International Society for Pediatric and Adolescent Diabetes
Diabetes Complications: Q&A Panel Discussion
- 15 views
- November 27, 2023
ISPAD - International Society for Pediatric and Adolescent Diabetes
Diabetic Kidney Disease in Young Persons with Diabetes: A Metabolic Disorder
FEATURING
Petter Bjornstad
- 334 views
- November 27, 2023
Stanford Medicine
Automated Insulin Delivery for INpatients with Dysglycemia (AIDING) Feasability Study
FEATURING
Michael Hughes
- 177 views
- November 28, 2023
- 2
Keck School of Medicine of USC
Should Obesity Be the Treatment Target in Type 2 Diabetes?
FEATURING
Jaime Almandoz
- 502 views
- November 30, 2023
- 4
Keck School of Medicine of USC
Effects of Low Calorie and Alternative Sweeteners Across the Lifespan: Magic Bullet or Fool's Gold
FEATURING
Michael Goran
- 6,997 views
- November 30, 2023
- 44